Optimal PSA Threshold for Androgen-Deprivation Therapy in Patients with Prostate Cancer following Radical Prostatectomy and Adjuvant Radiation Therapy.
Hyun Kyu AhnKwang-Suk LeeDaeho KimKoon Ho RhaSung Joon HongByung Ha ChungKyo Chul KooPublished in: Yonsei medical journal (2020)
Early ADT at the PSA level of less than 2 ng/mL confers CSS benefits in patients with localized or locally advanced PCa who were previously treated with RP.